| |
 The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is provided for 10.0 contact hours under ANCC criteria.
 This program has been reviewed and is approved for a maximum of 10.0 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Approval is valid for 1 year from the issue date of October 15, 2011. Participants may submit the self-assessment at any time during that period.
This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity was supported by educational grants from Abbott Laboratories; Astellas Pharma Inc.; Daiichi Sankyo, Inc.; Daiichi Sankyo, Inc. and Lilly USA, LLC; Endo Pharmaceuticals Inc.; Merck & Co., Inc.; Novo Nordisk; and sanofi-aventis.
Practicing Clinicians Exchange gratefully acknowledges the American Social Health Association, Miller Medical Communications, LLC., and Primary Care Education Consortium for their contributions as education partners for this program.
Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, American Academy of Physician Assistants, Practicing Clinicians Exchange, or any educational supporter.
Disclosures
All faculty and planners participating in continuing education activities sponsored by the University of Nebraska Medical Center College of Nursing Continuing Nursing Education are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Aldredge: advisory board: Abbott Laboratories, Centocor, Inc., LEO Pharma Inc., Ortho Dermatologics; speakers bureau: Abbott Laboratories, Centocor, Inc., Ortho Dermatologics.
Dr Altus has nothing to disclose with regard to commercial interests.
Dr Christiansen has nothing to disclose with regard to commercial interests.
Dr Guay: advisory board/consultant/honoraria: Abbott Laboratories, Auxilium Pharmaceuticals, Inc., Endo Pharmaceuticals Inc., Repros Therapeutics Inc., Trimel BioPharma.
Dr Handsfield: consultant: Merck & Co., Inc.
Dr Knudtson has nothing to disclose with regard to commercial interests.
Mr Largay: grant/research support: Amylin Pharmaceuticals, Inc., Andromeda Biotech, Ltd., Eli Lilly and Company, Halozyme Therapeutics, Hoffman-LaRoche Inc., Johnson & Johnson, Inc., Medtronic, Merck & Co., Inc., Novo Nordisk, Osiris Therapeutics Inc., Pfizer Inc, Tolerx, Inc.
Dr Shaefer: honoraria/speakers bureau: AstraZeneca, Bristol-Myers Squibb, Eli Lilly-Amylin Pharmaceuticals Alliance, Forest Laboratories, Inc., Novartis, sanofi-aventis; consultant: Eli Lilly-Amylin Pharmaceuticals Alliance, sanofi-aventis.
Mr Urquhart: honoraria: Abbott Laboratories, Warner Chilcott.
Dr Zusman: advisory board/research support/speakers bureau: Bristol-Myers Squibb, Eli Lilly and Company, Daiichi Sankyo, Co., Ltd., Forest Laboratories, Inc., Novartis, Pfizer Inc, Boehringer Ingelheim, sanofi-aventis.
The Planning Committee for this activity included Catherine A. Bevil, RN, EdD, and Kathleen Yao, MSN, APRN-WH, of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education; Mark P. Christiansen, PA-C, PhD, of the University of California Davis Medical Center; Lyerka D. Miller, PhD, of Miller Medical Communications, LLC.; Stephen Brunton, MD, of Primary Care Education Consortium; Fred L. Wyand of the American Social Health Association; and Christie Avraamides, PhD, Ruth Cohen, Margaret Inman, Susan J. Moench, PhD, PA-C, and Christine M. Olsen, PhD, of Practicing Clinicians Exchange. None of the aforementioned members have any significant relationships to disclose, except:
Dr Brunton: advisory board: Amylin Pharmaceuticals, Inc., Boehringer Ingelheim, Novo Nordisk.
|
